首页> 外国专利> METHOD FOR PREDICTION OF THE RISK OF DEVELOPING CHOROIDAL NEOVASCULARISATION (CNV) IN PATIENTS WITH MODERATE- AND HIGH-GRADE PATHOLOGICAL MYOPIA

METHOD FOR PREDICTION OF THE RISK OF DEVELOPING CHOROIDAL NEOVASCULARISATION (CNV) IN PATIENTS WITH MODERATE- AND HIGH-GRADE PATHOLOGICAL MYOPIA

机译:预测中度和高度病理性近视眼患者发展脉络膜神经硬化(CNV)的风险的方法

摘要

FIELD: medicine.;SUBSTANCE: invention relates to medicine, specifically to ophthalmology. Method for prediction of risk of developing choroidal neovascularization (CNV) in patients with pathological myopia of medium and high degree includes ophthalmoscopic examination to determine the presence of focal chorioretinal atrophy at the fundus and peripheral chorioretinal dystrophy (PVCHRD), as well as biometrics for measurement of axial length – anterior-posterior axis (APA) of the examined eye and spectral optical coherence tomography for measuring subfoveal thickness of the choroidal eye. Calculating the probability of predicting the risk of developing CNV in pathological myopia of medium and high degree P is calculated depending on detected predictors of its development of the disease. Nominal data with presence of focal choroidal atrophy and PVCHRD in past history are marked as 1, in absence – as 0. If there is no focal chorioretinal atrophy on the fundus and PVCHRD, calculating the probability of predicting the risk of developing CNV in pathological myopia of moderate and high degree of probability. Obtained value ranges from 0 to 1. Sensitivity of this logistic regression analysis is 89.50 %, specificity is 76.20 %, error-freeness is equal to 83.80 %.;EFFECT: establishment of optimal terms of dynamic observation of patients with pathological myoscopy.;1 cl
机译:技术领域本发明涉及医学,尤其涉及眼科。预测中度和高度病理性近视患者发生脉络膜新生血管(CNV)的风险的方法包括检眼镜镜检查以确定眼底和周围脉络膜视网膜营养不良(PVCHRD)是否存在局灶性脉络膜视网膜萎缩以及测量的生物特征轴向长度–被检眼的前后轴(APA)和光谱光学相干断层扫描技术,用于测量脉络膜眼的中央凹下厚度。根据检测到的疾病发展的预测因子,计算出预测中度和高度P病理性近视中发展CNV风险的概率。过去有局灶性脉络膜萎缩和PVCHRD的标称数据标记为1,不存在时标为0。如果眼底和PVCHRD上没有局灶性脉络膜视网膜萎缩,则计算预测在病理性近视中发展为CNV的风险的可能性中度和高度概率。获得的值范围为0到1。此逻辑回归分析的灵敏度为89.50%,特异性为76.20%,无误度等于83.80%。;效果:建立病理性肌镜检查患者动态观察的最佳条件。1 CL

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号